Scorpius Holdings, Inc. reported significant financial challenges in its latest 10-Q filing for the quarter ending September 30, 2025. The company generated revenue of $229,842 for the third quarter, a substantial decline from $922,365 in the same period last year. For the nine months ending September 30, 2025, total revenue was $669,640, down from $5.2 million in the prior year. The company also recorded a net loss of $1.2 million for the quarter, compared to a loss of $10.5 million in the same quarter of 2024, and a total net loss of $16.8 million for the nine months, down from $24.5 million in the previous year.
The financial performance reflects a drastic reduction in operational activity, primarily due to the cancellation and suspension of several customer contracts. The company’s largest customer, which contributed significantly to revenue in the previous year, migrated to a larger contract development and manufacturing organization (CDMO) in 2024. As a result, Scorpius has ceased operations and anticipates no revenue generation unless a strategic transaction, such as a merger or asset acquisition, is completed.
Operationally, Scorpius has faced severe setbacks, including the termination of its lease for a manufacturing facility in March 2025 due to non-payment of rent. This was followed by a foreclosure sale of its assets on December 10, 2025, which yielded $16.3 million but left the company with no operational assets. The company’s total assets decreased from $39.2 million at the end of 2024 to $20.8 million by September 30, 2025, primarily due to the loss of its manufacturing capabilities and the significant reduction in cash reserves, which stood at $581,608 at the end of the quarter.
In terms of strategic developments, Scorpius has been exploring various financing options to address its liquidity issues, including potential equity and debt offerings. However, the company has expressed substantial doubt about its ability to continue as a going concern, given its accumulated deficit of $303 million and the lack of operational revenue. The company’s management has indicated that without additional funding or a successful strategic transaction, it may need to consider bankruptcy or liquidation.
Looking ahead, Scorpius Holdings is in a precarious position, with no immediate plans for revenue generation and a pressing need for capital to sustain its public operations. The company’s future hinges on its ability to secure financing or find a suitable merger candidate, but management has acknowledged the uncertainty surrounding these efforts. The ongoing status as a "Shell Company" further complicates its ability to attract investors, as it lacks operational assets and revenue-generating capabilities.
About Scorpius Holdings, Inc.
Scorpius Holdings, Inc. is a contract development and manufacturing organization (CDMO) specializing in biologics, cell- and gene-based therapies, and large molecule biologics. It offers process development, CGMP manufacturing, and quality control services primarily to biotech and pharma clients. The company operates a modern facility in Texas, supports U.S. government contracts, and emphasizes American-made equipment and domestic sourcing to enhance competitiveness.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.